The fertility and pregnancy outcomes of the patients who underwent preservative operation followed by adjuvant chemotherapy for malignant ovarian tumors

Archives of Gynecology and Obstetrics

Volumn 264, Issue 3, 2000, Pages 124-127

  Yoshinaka, A ^a   Fukasawa, I ^a   Sakamoto, T ^a   Tanaka, M ^a   Ota, Y ^a   Inaba, N ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adjuvant chemotherapy; Fertility; Germ cell tumor; Malignant ovarian tumor; Preservative operation

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; GONADOTROPIN; PEPLEOMYCIN; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CHILD; CLINICAL ARTICLE; FEMALE; FERTILITY; GERM CELL TUMOR; HUMAN; OVARY CANCER; PREGNANCY COMPLICATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; FEMALE; FERTILITY; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PREGNANCY; PREGNANCY OUTCOME;

EID: 0033711291     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004040000094     Document Type: Article

References (21)

1. Current management of malignant germ cell tumor of the ovary
2. Limited surgery in ovarian cancer: Experience on 164 cases, 2nd Int
3. Prevention of gonadal damage during cytotoxic therapy
4. Chemotherapy for ovarian germ cell tumours
5. Controversial issues in the management of early epitherial ovarian cancer. Conservative surgery and role of adjuvant therapy
6. Ovarian failure and cancer treatment - Incidence and interventions for the premenopausal women
7. L-phenylalanine mustard (L-PAN) in the management of premenopausal patients with primary breast cancer
8. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors
9. Endodermal sinus tumor of the ovary: The M.D. Anderson Experience
10. Results of fertility preserving surgery of malignant ovarian tumors
11. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer
12. Cyclophosphamide and reproductive function
13. Spontaneous recovery of chemotherapy-induced primary ovarian failure: Implication for management
14. Pregnancies following conservative treatment of malignant ovarian tumors
15. Amenorrhoea in patients with Hodgikin's disease treated with antineoplastic agents
16. Quantitative evaluation for murine oocyte toxicity following intraperitoneal treatment with chemotherapeutic agents
17. Pregnancy in a patient with premature ovarian failure secondary to chemotherapy
18. Malignant ovarian neoplasms: The place of conservative surgery
19. Sterility and cyclophosphamide
20. Gonadal dysfunction due to cis-platinum
21. Conservative surgery for the preservation of fertility in malignant ovarian germ cell tumors